Navigation Links
EntreMed Secures $10 Million Strategic Financing
Date:1/23/2012

onal needs; our reliance on a single product candidate, ENMD-2076 and the risk that we may not be able to license it to a third party; the volatility of our common stock; our history of losses and expectation of incurring continued losses; risks relating to the need for additional capital, including the uncertainty of securing additional funding on favorable terms and the risk that we will not be able to drawdown the full amount of funding available under our standby equity distribution agreement; the need for additional funds to conduct any additional clinical trials,  our dependence on royalty sharing agreement based on sales of a product, Thalomid®, that we do not control; declines in actual sales of Thalomid® resulting in materially reduced royalty payments; risks associated with our product candidates; results in preclinical models that are not necessarily indicative of clinical results;  risks relating to the commercialization, if any, of our  proposed products (such as marketing, safety, regulatory, patent, product liability, supply and other risks); and our ability to compete with larger, better financed biotechnology companies that may develop new approaches to the treatment of our targeted diseases or develop product candidates more advanced than ENMD-2076.  Such factors, among others, could have a material adverse effect upon our business, results of operations and financial condition.  We caution readers not to place undue reliance on any forward-looking statements, which only speak as of the date made. Additional information about the factors and risks that could affect our business, financial condition and results of operations, are contained in our filings with the SEC, which are available at www.sec.gov.

COMPANY CONTACT:
Investor Relations
EntreMed, Inc.
240.864.2643
inve
'/>"/>

SOURCE EntreMed
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer
2. EntreMed Raises $20 Million to Support Clinical Development Program
3. EntreMed Reports Phase 1 PK and Preclinical Efficacy Results for ENMD-1198
4. EntreMed Shows Increased Survival With MKC-1 in Preclinical Renal Cell Cancer Model
5. EntreMed Commences Phase 2 Study with MKC-1 in Pancreatic Cancer
6. EntreMed to Present at The New York Society of Security Analysts Industry Conference
7. EntreMed Commences Phase 2 Study With MKC-1 in Ovarian/Endometrial Cancers
8. EntreMed Commences Continuous Dosing Clinical Trial For MKC-1
9. EntreMed Achieves a Key Milestone Through Initiation of ENMD-2076 Clinical Program
10. EntreMed to Highlight ENMD-2076 Kinase Inhibitor at 2008 AACR Annual Meeting
11. EntreMed Presents MKC-1 and ENMD-1198 Preclinical Data at AACR Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)...  Northstar Global Business Services, Inc. (OTCPink:MDIN) today ... made their final decision and has determined to ... effective December 15, 2014, and has resumed accepting ... book entry transfer services. All deposit restrictions have been ... fully "DTC Eligible", and has resumed electronic trading ...
(Date:12/17/2014)... , The new ... of information concerning the biopharmaceutical Group,s national and international clinical ... to the recently launched institutional website that is receiving accolades ... by a new chapter in the fascinating story of Drug ... and panoramic hub on the world of clinical research, ranging ...
(Date:12/17/2014)... Mass. , Dec. 17, 2014  RXi ... biotechnology company focused on discovering, developing and commercializing ... RNA-targeted technologies, today announced completion of enrollment in its ... from the 3-month observations confirmed the 1-month findings ... Logo - http://photos.prnewswire.com/prnh/20130917/NE80755LOGO ...
Breaking Medicine Technology:Northstar announces that the DTC chill on MDIN has been officially lifted 2Northstar announces that the DTC chill on MDIN has been officially lifted 3Dompé Offers a New "Window" on the World of Scientific Research, with the http://www.dompetrials.com Website, Dedicated to Clinical Trials 2Dompé Offers a New "Window" on the World of Scientific Research, with the http://www.dompetrials.com Website, Dedicated to Clinical Trials 3RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 2RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 3RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 4RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 5
... Md., Nov. 4, 2010 The U.S. Food ... to treat chronic musculoskeletal pain, including discomfort from ... first used to treat major depressive disorder in ... (Logo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO ) ...
... Calif., Nov. 4, 2010 ThermoGenesis Corp. (Nasdaq: ... and services that process and store adult stem cells, ... China and Hong Kong for its products used to ... at the point-of-care and in the laboratory. ...
Cached Medicine Technology:FDA Clears Cymbalta to Treat Chronic Musculoskeletal Pain 2ThermoGenesis Signs Major Bone Marrow Product Distribution Agreement in China 2ThermoGenesis Signs Major Bone Marrow Product Distribution Agreement in China 3ThermoGenesis Signs Major Bone Marrow Product Distribution Agreement in China 4ThermoGenesis Signs Major Bone Marrow Product Distribution Agreement in China 5
(Date:12/17/2014)... 17, 2014 This prestigious award ... that have made outstanding and innovative contributions to ... progression of private practice physical therapy by the ... Association. , On behalf of Performance Physical Therapy, ... CEO of Performance accepted the award at the ...
(Date:12/17/2014)... December 17, 2014 No matter how ... able to eradicate the head louse parasite—a common childhood ... parents. Each year between six and twelve million individuals ... Miami-based lice removal treatment company comes to the rescue, ... environmentally friendly. With its track record of customer service, ...
(Date:12/17/2014)... Alan Mozes HealthDay Reporter ... the world of infectious diseases, one worrisome phenomenon is when ... The process -- known as zoonosis -- is not ... for signs that an animal-borne disease might make inroads into ... such a development -- and the culprits in this case ...
(Date:12/17/2014)... HealthDay Reporter TUESDAY, Dec. 16, ... approaching, a new study reveals that states that routinely perform ... drivers on their roads. The finding suggests that states ... to deter inebriated revelers from getting behind the wheel in ... passed regarding drinking and driving," said study lead author James ...
(Date:12/15/2014)... 15, 2014 Cancer researchers have just ... genetic causes of deadly malignant pleural mesothelioma. Surviving Mesothelioma ... their website. Click here to read it now. ... Hawaii Cancer Center, and New York’s Langone Medical Center ... mesothelioma patients in an effort to pinpoint the ...
Breaking Medicine News(10 mins):Health News:Performance Physical Therapy Awarded with Jayne L. Snyder Private Practice of the Year 2014 2Health News:Lice Troopers Announces New Lice Treatment Clinic in Coral Gables to Service Key Biscayne, Coconut Grove, Kendall, Brickell & South Miami 2Health News:Guinea Pigs Can Be Source of Serious Strep Infection 2Health News:Guinea Pigs Can Be Source of Serious Strep Infection 3Health News:Enforcement of Drunk Driving Laws Makes Roads Safer, Study Finds 2Health News:Enforcement of Drunk Driving Laws Makes Roads Safer, Study Finds 3Health News:New Study Reveals Genetic Mutations That May Trigger Mesothelioma, According to Surviving Mesothelioma 2
... July 7 The American Association of Homes and ... Administration for affirming their commitment to the millions of ... In a letter to the Senate Health, Education, Labor ... Human Services Secretary Kathleen Sebelius expressed the Obama,s administration,s ...
... Institute for Clinical Systems Improvement (ICSI) will hold a symposium ... is dramatically improving patient outcomes and lowering the cost of ... program changes how care for the patient with depression is ... will focus on the 18-month experiences of provider groups, behavioral ...
... relatives reveals clues about course of illness, prognosis, research shows ... history not only reveals their risk for conditions such as ... predict the course of the illness and prognosis, a new ... New Zealand, who were enrolled at age 3 and followed ...
... Comprehensive regulation of gun sellers appears to reduce the ... led by researchers at the Johns Hopkins Bloomberg School ... criminals is important because 85 percent of guns recovered ... not the original purchasers of the guns according to ...
... of early death and disability in Europe, accounting each year ... costing the EU economy an estimated 192 billion. Top level ... to assess current prevention programs and to develop a strategy ... by the European Heart Network and the European Society of ...
... five and a half pounds at birth often enter ... respiratory problems. New research shows that these respiratory problems ... into adulthood. "We report a previously unrecognized ... adults with a history of low birth weight," wrote ...
Cached Medicine News:Health News:Obama Administration Advances Long-Term Services and Supports in Health Care Reform 2Health News:ICSI Plans Symposium on New Depression Treatment Program That Is Improving Patient Outcomes Five-Fold Over Typical Primary Care 2Health News:Family History Key to Psychiatric Disorder Risk 2Health News:Regulation and oversight of gun sales reduces trafficking to criminals 2Health News:Regulation and oversight of gun sales reduces trafficking to criminals 3Health News:Low birth weight linked to long-term respiratory problems 2Health News:Low birth weight linked to long-term respiratory problems 3
... Vest-Skirt Combination gives you the ... Comfort enhanced by distributing 70% ... the hips leaving only 30% ... the shoulders. Freedom of movement ...
One standard,size fits all....
Front protection with choice of adjustable 2" buckle or velcro belt which crosses the back for a comfortable fit. Adjustable straps at shoulders keeps apron snug....
... to help lift the weight off your shoulders ... around protection to cover you front, side and ... a breeze. For additional back support try one ... pressure on the vertebrae and help "lift the ...
Medicine Products: